Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37

Molecular Microbiology

Volumn 46, Issue 1, 2002, Pages 157-168

  Schmidtchen, Artur ^a   Frick, Inga Maria ^b   Andersson, Emma ^a   Tapper, Hans ^b   Björck, Lars ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; ARGININE; ASPARAGINE; ASPARTIC ACID; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMICAL COMPOUND; DERMATAN SULFATE; DISACCHARIDE; ILOMASTAT; ISOLEUCINE; LEUCINE; METALLOPROTEINASE INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPTIDE; PHENYLALANINE; PROTEINASE; SUCROSE OCTASULFATE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; IMMUNE SYSTEM; MASS SPECTROMETRY; NONHUMAN; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PYOGENES; WOUND;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; DISACCHARIDES; ENDOPEPTIDASES; GLYCOSAMINOGLYCANS; HUMANS; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PANCREATIC ELASTASE; PROTEASE INHIBITORS; PSEUDOMONAS AERUGINOSA; SULFUR; VIRULENCE; WOUND INFECTION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; MIRABILIS; NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PYOGENES;

EID: 0036030617     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2002.03146.x     Document Type: Article

References (49)

1. Agerberth, B., Grunewald, J., Castanos-Velez, E., Olsson, B., Jörnvall, H., Wigzell, H.,et al. (1999) Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med 160: 283-290.
2. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., et al. (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96: 3086-3093.
3. Bals, R., Wang, X., Zasloff, M., and Wilson, J.M. (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 95: 9541-9546.
4. Björck, L., Åkesson, P., Bohus, M., Trojnar, J., Abrahamson, M., Olafsson, I., and Grubb, A. (1989) Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 337: 385-386.
5. Boman, H.G. (2000) Innate immunity and the normal microflora. Immunol Rev 173: 5-16.
6. Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117: 91-97.
7. Ernst, R.K., Yi, E.C., Guo, L., Lim, K.B., Burns, J.L., Hackett, M., and Miller, S.I. (1999) Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286: 1561-1565.
8. Folkman, J., Szabo, S., Stovroff, M., McNeil, P., Li, W., and Shing, Y. (1991) Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214: 414-425.
9. Fransson, L.-Å., Nieduszynski, I.A., Phelps, C.F., and Sheehan, J.K. (1979) Interactions between dermatan sulphate chains. III light scattering and viscometry studies of self association. Biochem Biophys Acta 586: 179-188.
10. Frohm, M., Agerberth, B., Ahangari, G., Ståhle-Bäckdahl, M., Liden, S., Wigzell, H., and Gudmundsson, G.H. (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272: 15258-15263.
11. Frohm, M., Gunne, H., Bergman, A.C., Agerberth, B., Bergman, T., Boman, A., et al. (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237: 86-92.
12. Frohm-Nilsson, M. (2001)The human antimicrobial peptide hCAP18 in epithelial defence. Doctoral Dissertation. Department of Dermatology, Karolinska Hospital, Karolinska Institute, Sweden.
13. Fukushima, J., Yamamoto, S., Morihara, K., Atsumi, Y., Takeuchi, H., Kawamoto, S., and Okuda, K. (1989) Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase. J Bacteriol 171: 1698-1704.
14. Gallo, R.L., Ono, M., Povsic, T., Page, C., Eriksson, E., Klagsbrun, M., and Bernfield, M. (1994) Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 91: 11035-11039.
15. Gerlach, D., Knöll, H., Köhler, W., Ozegowski, J.-H., and Hribalova, V. (1983) Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Mikrobiol Hyg 225: 221-233.
16. Hancock, R.E., and Scott, M.G. (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97: 8856-8861.
17. Hansson, C., Hoborn, J., Möller, Å., and Swanbeck, G. (1995) The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 75: 24-30.
18. Herwald, H., Collin, M., Müller-Esterl, W., and Björck, L. (1996) Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J Exp Med 184: 665-673.
19. Huang, H.J., Ross, C.R., and Blecha, F. (1997) Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. J Leukoc Biol 61: 624-629.
20. Islam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., and Gudmundsson, G. (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180-185.
21. Kinoshita, A., Yamada, S., Haslam, S.M., Morris, H.R., Dell, A., and Suguhara, K. (2001) Isolation and structural determination of novel sulfated hexasaccharides from squid cartilage chondroitin sulfate E that exhibits neuroregulatory activities. Biochemistry 40: 12654-12665.
22. Klagsbrun, M. (1992) Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF) - heparin and heparan sulfate interactions. Semin Cancer Biol 3: 81-87.
23. de Kreij, A., Venema, G., and van den Burg, B. (2000) Substrate specificity in the highly heterogeneous M4 peptidase family is determined by a small subset of amino acids. J Biol Chem 275: 31115-31120.
24. Lehrer, R.I., and Ganz, T. (1999) Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11: 23-27.
25. Lysenko, E.S., Gould, J., Bals, R., Wilson, J.M., and Weiser, J.N. (2000) Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect Immun 68: 1664-1671.
26. Malm, J., Sörensen, O. Persson, Frohm-Nilsson, M., Johansson, B., Bjartell, A., et al. (2000) The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun 68: 4297-4302.
27. Morihara, K., Tsuzuki, H., Oka, T., Inoue, H., and Ebata, M. (1965) Pseudomonas aeruginosa elastase isolation, crystallization, and preliminary characterization. J Biol Chem 240: 3295-3304.
28. Nagaoka, I., Hirota, S., Yomogida, S., Ohwada, A., and Hirata (2000) Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res 49: 73-79.
29. Nizet, V., Ohtake, Lauth, T., Trowbridge, X., Rudisill, J., Dorschner, J.R.A., et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
30. Okamoto, T., Akaike, T., Suga, M., Tanase, S., Horie, H., Miyajima, S., et al. (1997) Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem 272: 6059-6066.
31. Okuda, K., Morihara, K., Atsumi, Y., Takeuchi, H., Kawamoto, S., Kawasaki, H., et al. (1990) Complete nucleotide sequence of the structural gene for alkaline proteinase from Pseudomonas aeruginosa IFO 3455. Infect Immun 58: 4083-4088.
32. Oren, Z., Lerman, J.C., Gudmundsson, G., Agerberth, B., and Shai, Y. (1999) Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 341: 501-513.
33. Park, P.W., Pier, G.B., Hinkes, M.T., and Bernfield, M. (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411: 98-102.
34. Penc, S.F., Pomahac, B., Winkler, T., Dorschner, R.A., Eriksson, E., Herndon, M., and Gallo, R.L. (1998) Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem 273: 28116-28121.
35. Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., et al. (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193: 1067-1076.
36. Rodén, L., Baker, J., Cifonelli, J.A., and Mathews, M.B. (1973) Methods in Enzymology. Ginsburg V. (ed). Vol. 28. New York: Academic Press, pp. 73-140.
37. Rozalski, A., Sidorczyk, Z., and Kotelko, K. (1997) Potential virulence factors of Proteus Bacilli. Microbiol Mol Biol Rev 61: 65-89.
38. Schmidtchen, A. (2000) Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers. Acta Derm Venereol 80: 179-184.
39. Schmidtchen, A., Wolff, H., and Hansson, C. (2001a) Differential protease expression by Pseudomonas aeruginosa derived from venous leg ulcers. Acta Derm Venereol 81: 406-409.
40. Schmidtchen, A., Frick, I.-M., and Björck, L. (2001b) Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial α-defensin. Mol Microbiol 39: 708-713.
41. Schröder, J.-M., and Harder, J. (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31: 645-651.
42. Selsted, M.E., and Ouellette, A.J. (1995) Defensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol 5: 114-119.
43. Shafer, W.M., Qu, X., Waring, A.J., and Lehrer, R.I. (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci USA 95: 1829-1833.
44. Sörensen, O.E., Follin, P., Johnsen, A.H., Calafat, J., Tjabranga, G.S., Hiemstra, P.S., and Borregaard, N. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
45. Steiner, H., Hultmark, D., Engström, A., Bennich, H., and Boman, H.G. (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292: 246-248.
46. Travis, J., Potempa, J., and Maeda, H. (1995) Are bacterial proteinases pathogenic factors? Trends Microbiol 3: 405-407.
47. Wang, Y., Agerberth, B., Löthgren, A., Almstedt, A., and Johansson, J. (1998) Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem 273: 33115-33118.
48. Yang, D., Chertov, O., and Oppenheim, J.J. (2001) Participation of mammalian defensins and cathelicidins in antimicrobial immunity receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 69: 691-697.
49. Zanetti, M., Gennaro, R., and Romeo, D. (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374: 1-5.